Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal Stem Cell Function in a Human Organotypic Model of Dyskeratosis Congenita
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary Patients with dyskeratosis congenita (DC) suffer from stem cell failure in highly proliferative tissues including the intestinal epithelium. Few therapeutic options exist for this disorder, and patients are treated primarily with bone marrow transplantation to restore hematopoietic function. Here, we generate isogenic DC patient and disease allele-corrected intestinal tissue using CRISPR/Cas9-mediated gene correction in induced pluripotent stem cells and directed differentiation. We show DC tissue has sub-optimal Wnt pathway activity causing intestinal stem cell failure, and that enhanced expression of the telomere capping protein TRF2, a Wnt target gene, can alleviate DC phenotypes. Treatment with clinically relevant Wnt agonists LiCl or CHIR99021 restored TRF2 expression and reversed gastrointestinal DC phenotypes, including organoid formation in vitro, and maturation of intestinal tissue and xenografted organoids in vivo. Thus, the isogenic DC cell model provides a platform for therapeutic discovery and identifies Wnt modulation as a potential strategy for treatment of DC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299 · cited 2×
“Isogenic pairs of DC and control lines were generated using CRISPR/Cas9n (D10A) nickase (Ran et al., 2013) along with single-stranded DNA (ssDNA) donor templates for homology-directed repair (in the DC iPSCs) as well as introduction of theDKC1mutation (in wild-type iPSCs) (Figures 1A and 1B; Table…”
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 1×
“Next, we investigated whetherWnt agonism also rescued telomere capping by analyzing telomere dysfunction-induced foci (TIFs), measured by colocalization of telomeres with 53BP1 (Herbig et al., 2004).”
BackgroundArmanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982 · cited 1×
“Dyskeratosis congenita (DC) is a debilitating disorder caused primarily by mutations in the DKC1 gene that encodes DYSKERIN, a protein critical for telomerase complex function, leading to failures in telomere maintenance (Armanios and Blackburn, 2012; Savage, 2014).”
BackgroundDyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
Hao, L.-Y., Armanios, M., Strong, M. A., Karim, B., Feldser, D. M., Huso, D., & Greider, C. W. (2005) · Cell · doi:10.1016/j.cell.2005.11.020 · Cited by 302 · cited 2×
“mTR / mice exhibit stem cell failure (Hao et al., 2005; Tao et al., 2015) and downregulation of Wnt pathway target genes, resulting in compromised intestinal barrier function (Tao et al.”
BackgroundLeroy, K., Ando, K., Héraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J.-P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1276 · Cited by 103 · cited 1×
“Ultimately, we asked whether DKC1 mutant HIOs would respond to systemic administration of a clinically utilized Wnt agonist (lithium salts) at a clinically relevant dosage in vivo (Leroy et al., 2010; O’Brien et al., 2004).”
Background
Cited by
Hofer, M., & Lutolf, M. P. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00279-y · Cited by 1,184
Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
Kim, H., Park, H. J., Choi, H., Chang, Y., Park, H., Shin, J., Kim, J., Lengner, C. J., Lee, Y. K., & Kim, J. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.020 · Cited by 346
Self-citationBioengineering Approaches for the Advanced Organoid Research
Yi, S. A., Zhang, Y., Rathnam, C., Pongkulapa, T., & Lee, K. (2021) · Advanced Materials · doi:10.1002/adma.202007949 · Cited by 218
Genetic engineering in organoids
Teriyapirom, I., Batista-Rocha, A. S., & Koo, B.-K. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02029-z · Cited by 68
“Woo and colleagues used the CRISPR/Cas9 system to generate iPSCs with a mutation in the DKC1 gene, which encodes DYSKERIN, a protein essential in telomere maintenance [118].”
BackgroundMethodWnt Signaling Mediates the Aging-Induced Differentiation Impairment of Intestinal Stem Cells
Cui, H., Tang, D., Garside, G. B., Zeng, T., Wang, Y., Tao, Z., Zhang, L., & Tao, S. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09880-9 · Cited by 57
Novelli, G., Spitalieri, P., Murdocca, M., Centanini, E., & Sangiuolo, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059579 · Cited by 43
“Dyskeratosis congenital (DKC1 gene) (Woo et al., 2016)*”
The future of cerebral organoids in drug discovery
Salick, M. R., Lubeck, E., Riesselman, A., & Kaykas, A. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.05.024 · Cited by 29
Organotypic cultures as aging associated disease models
Sanchez, M. M., Bagdasarian, I. A., Darch, W., & Morgan, J. T. (2022) · Aging · doi:10.18632/aging.204361 · Cited by 12
Metadata
- Authors
- Woo, D.-H., Chen, Q., Yang, T.-L. B., Glineburg, M. R., Hoge, C., Leu, N. A., Johnson, F. B., & Lengner, C. J.
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 19
- Issue
- 3
- Pages
- 397-405
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W2509722695
- Cited by
- 60
- References
- 6
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.